Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$375,070.00
Feb 17, 2026
For-profit organization
ADAPT: Accessible Diagnostics for Aging-in-Place Testing
1039268
The ADAPT platform combines the NRC’s latest innovations in microfluidics-powered technologies with LFAnt medical’s next generation electromagnetic biosensors.
$550,000.00
Mar 10, 2025
For-profit organization
Grant Agreement for the Innovative Solutions Canada Program, Project -Chick-Flu-A
ISC-20364-Ph2
This process is time consuming, labour intensive and requires expensive laboratory equipment. 11281232 Canada Inc. (LFAnt Medical) aims to develop an easy-to-use, rapid, and affordable lateral flow test for the detection of AI in the field.
$150,000.00
Mar 31, 2024
For-profit organization
Grant Agreement for the Innovative Solutions Canada Program, Project -Chick-Flu-A
ISC-20364-Ph1
Avian Influenza (AI) is a contagious viral infection that can cause severe illness and mortality in gallinaceous poultry (chicken, turkey, quails). It also has the potential to cross over to mammals, including companion animals such as cats and dogs. AI is currently diagnosed in the Canadian Food Inspection Agency (CFIA) laboratories by molecular methods. This process is time consuming, labour intensive and requires expensive laboratory equipment. 11281232 Canada Inc. aims to develop an easy-to-use, rapid and affordable lateral flow test for the detection of AI in the field. The proposed method involves the use of magnetic nanoparticles in combination with a magnetic lateral flow assay reader to detect AI and at the same time, H5 and H7 subtypes, with the same sensitivity and specificity as current molecular diagnostic tests used in the CFIA laboratory.
$24,000.00
Jun 21, 2021
For-profit organization
Optimization of a PCB/LFA System for the Detection of Infectious Diseases
974516
The project is to develop a digitized rapid diagnostic test for the at-home detection of Sexually Transmitted Diseases (STI), enabling improved sensitivity, user-friendliness, and connection with tele-medicine platforms.
$100,000.00
Sep 6, 2020
For-profit organization
Molecular Assay for Instrumentless SARS-CoV-2 Rapid Diagnostic from Saliva
956621
LFAnt is developing two distinct proof-of-concept instrument-less colorimetric liquid assays for the rapid saliva-based detection of (1) the SARS-CoV-2 virus and (2) its associated antibodies. LFANT's colorimetric liquid assay technology is
based on the salt-induced aggregation and change in colour of aptamer-shielded gold nanoparticle (AuNP) solutions in the presence of aptamer-specific molecular targets. This Project includes the development of both novel reagent and assay
solutions for potential integration into a saliva collection and processing device being developed by the NRC to provide a sample-to-answer system capable of detecting SARS-CoV-2 and COVID-19 immune response, respectively, within 15
minutes using only a simple visual result readout.
$29,999.84
Sep 1, 2020
For-profit organization
YEP - Development of a novel electronic lateral flow assay casing
956451
Development of a point-of-care medical device for disease detection.